77 more hepatitis cases may trace to clinic, officials say
LAS VEGAS -- Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said. Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist
77 more hepatitis cases may trace to clinic at center of Las Vegas outbreak, officials say
AM LAS VEGAS-Seventy-seven more people that were treated at a Las Vegas outpatient clinic accused of reusing syringes on thousands of people have been diagnosed with Hepatitis C, health officials said. Authorities cannot say for sure how the 77 people
77 more hepatitis cases may trace to clinic, officials say
Seventy-seven more people that were treated at a Las Vegas outpatient clinic have been diagnosed with hepatitis C, health officials said.Authorities can't say for sure how the 77 people were infected, said Brian Labus, senior epidemiologist with the
|
|
|
Highly Effective Against HCV Genotype 1
When tested on people with Hepatitis C genotype 1, R7128 proved to be an effective addition to combination therapy after just four weeks' time. In addition to its anti-viral effect, polymerase inhibitor R7128 received good marks for safety and minimal...
Investigational Drug Beats Standard Therapy in Hepatitis C Study
A Phase IIa trial investigating triple combination therapy with PEGASYS, COPEGUS and Roche's investigational drug R1626, demonstrated a higher response rate than traditional combination therapy alone. While R1626's effectiveness and high barrier to resistance makes it a top Hepatitis C...
Hepatitis C Complications Helped by Maintenance Interferon
A four-year study confirms that low-dosage maintenance interferon therapy prevents disease progression in those with portal hypertension or cirrhosis from Hepatitis C....
|
|
|
Site Map
Last updated:
2007, March 22 Total pages: 1983
|
sept/24 pages
|
|
2004/1 pages
|
|
alternative/1 pages
|
|
cdc/14 pages
|
|
hcv/9 pages
|
|
info/78 pages
|
|
posters-brochures/6 pages
|
|
va/6 pages
|
|
outcome/11 pages
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis, Current Information On Hepatitis C & treatments for
the medical professional and patient. |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Determinants of Outcome of Compensated Hepatitis C Virus-Related
Cirrhosis |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. | |
|
iron/9 pages
| Hepatitis
C, Iron & Hepatitis C table Of Contents |
| Hepatitis
C, Iron Loading and Disease Surveillance |
| Hepatitis
C, Effect of blood letting on serum aminotransferase levels of
patients with chronic hepatitis C and iron overload. |
| Hepatitis
C, A pilot randomized, controlled trial of the effect of iron
depletion on long-term response to alpha-interferon in patients with
chronic hepatitis C |
| Hepatitis
C, The advantage of gastrectomized patients in management of their
chronic hepatitis C |
| Hepatitis
C, Effect of iron depletion on long-term response to
interferon-alpha in patients with chronic hepatitis C |
| Hepatitis
C, Therapy of hepatitis C: other options |
| Hepatitis
C, Retreatment of hepatitis C interferon non-responders with larger
doses of interferon with and without phlebotomy |
| Hepatitis
C, Iron stores, response to alpha-interferon therapy, and effects of
iron depletion in chronic hepatitis C | |
|
labs/29 pages
| Hepatitis
C, Lab Tests, Laboratory Tests, Bilirubin, AST, ALT, Liver
panel, |
| Hepatitis
C, Alcoholic Liver Disease, Liver Failure and Chronic Liver
Disease |
| Hepatitis
C, Bilirubin analysis, Current Information On Hepatitis C &
treatments for the medical professional and patient. |
| Hepatitis
C, Frequently Asked Questions about AST, ALT,GGTP, AP, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Hepatitis Clinical Trials, Current Information On Hepatitis C
& treatments for the medical professional and patient. |
| Hepatitis
C, Standard Reporting The International Normalized Ratio (INR),
Current Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Single ELISA is Adequate, Even When Results are Weak, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Alpha fetoprotein, Current Information On Hepatitis C &
treatments for the medical professional and patient. |
| Hepatitis
C, Alkaline Phosphatase, ALP, Current Information On Hepatitis C
& treatments for the medical professional and patient. |
| Hepatitis
C, GGT and 5'-NT, Gammaglutamyltransferase, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Prothrombin Time, PT, and Serum Albumin, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Blood Ammonia, Current Information On Hepatitis C &
treatments for the medical professional and patient. |
| Hepatitis
C, Cholic acid, chenodeoxycholic acid, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Alpha-Fetoprotein, AFP, Current Information On Hepatitis C &
treatments for the medical professional and patient. |
| Hepatitis
C, Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT),
Current Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Caffeine Metabolism, Current Information On Hepatitis C &
treatments for the medical professional and patient. |
| Hepatitis
C, Bili-Alb, Conjugated bilirubin covalently bound to albumin,
Current Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Bilirubin in Biliary Obstruction, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Congenital disorders in bilirubin metabolism, Current Information
On Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Serum total bilirubin is increased in hepatocellular damage,
Current Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Hepatitis A General Clinical Tests, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Hepatitis C RNA General Clinical Tests, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Hepatitis D General Clinical Tests,Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Hepatitis B Core Antibody General Clinical Tests, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Hepatitis B DNA General Clinical Tests, Current Information On
Hepatitis C & treatments for the medical professional and
patient. |
| Hepatitis
C, Hepatitis B Surface Antibody General Clinical Tests, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Hepatitis B Surface Antigen General Clinical Tests, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, Hepatitis Be Surface Antigen and Antibody, Current Information On
Hepatitis C & treatments for the medical professional and
patient. | |
|
links/1 pages
|
|
liver/39 pages
| Hepatitis
C, Cirrhosis of the Liver Contents |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Damage Scores for Liver Biopsy. |
| Hepatitis
C, Q-T interval prolongation in cirrhosis: prevalence, relationship
with severity, and etiology of the disease and possible pathogenetic
factors. Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Complications of Cirrhosis, Current Information On Hepatitis C
& treatments for the medical professional and patient. |
| Hepatitis
C, Cirrhosis, Current Information On Hepatitis C & treatments
for the medical professional and patient. |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Cirrhosis, Current Information On Hepatitis C & treatments
for the medical professional and patient. |
| Hepatitis
C, Fibrosis & Cirrhosis, Current Information On Hepatitis C
& treatments for the medical professional and patient. |
| Hepatitis
C, Cirrhosis Symptoms and Signs, Current Information On Hepatitis C
& treatments for the medical professional and patient. |
| Hepatitis
C, Formulation and application of a numerical scoring system for
assessing histological activity in asymptomatic chronic active
hepatitis. |
| Hepatitis
C, Current Information On Hepatitis C & treatments for the
medical professional and patient. |
| Hepatitis
C, Liver Pain, Current Information On Hepatitis C & treatments
for the medical professional and patient. |
| Hepatitis
C, Liver Photos, Alcoholic Cirrhosis, Congestive Cirrhosis,
etc. |
| Hepatitis
C, Cirrhosis |
| Hepatitis
C, Long-term outcome of patients transplanted with livers from
hepatitis C-positive donors |
| Hepatitis
C, Liver Graphics |
| Hepatitis
C, Long-term evolution of fibrosis from chronic hepatitis to
cirrhosis in patients with hepatitis C: morphometric analysis of
repeated biopsies. |
| Hepatitis
C, Inflammation of the Liver |
| Hepatitis
C, Caring For Your Liver |
| Hepatitis
C, Frequently Asked Questions about AST, ALT, GGTP, AP |
| Hepatitis
C, Effect of shunt surgery on spleen size, portal pressure and
esophageal varices in patients with non-cirrhotic portal
hypertension |
| Hepatitis
C, Portal Hypertension Contents, |
| Hepatitis
C, Slow Intestinal Transit and Gallstones |
| Hepatitis
C, HCV genotypes in patients with liver disease of different stages
and severity |
| Hepatitis
C, Liver damage score--a new index for evaluation of the severity of
chronic liver diseases. |
| Hepatitis
C, Granulomatous Hepatitis |
| Hepatitis
C, Benefit of prophylactic endoscopic sclerotherapy of esophageal
varices. A retrospective analysis. |
| Hepatitis
C, Prevention of variceal rebleeding |
| Hepatitis
C, Gastroenterology: Ascites |
| Hepatitis
C, Alcoholic Liver Disease, Liver Failure and Chronic Liver
Disease |
| Hepatitis
C, Liver Dialysis Unit |
| Hepatitis
C - HCV |
| Hepatitis
C, Controversial Issues in HCV |
| Hepatitis
C, Portal Hypertensive Bleeding |
| Hepatitis
C, Portal Hypertension |
| Hepatitis
C, Portal Hypertension, Pathogenesis |
| Hepatitis
C, Portal Hypertension, Symptoms, Signs, and Diagnosis |
| Hepatitis
C, Portal Hypertension, Prognosis and
Treatment | |
|
alcoholic/1 pages
|
|
cancer/4 pages
|
|
cirrhosis/9 pages
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. |
| Hepatitis
C, High Prevalence of Sleep Disturbance in Cirrhosis, Current
Information On Hepatitis C & treatments for the medical
professional and patient. | |
|
esophageal/1 pages
|
|
ethanol/7 pages
| Hepatitis
C, Effects of Chronic Ethanol Administration on Rat Liver Proteasome
Activities: Relationship With Oxidative Stress |
| Hepatitis
C, Figure 1, Effects of Chronic Ethanol Administration on Rat Liver
Proteasome Activities: Relationship With Oxidative Stress |
| Hepatitis
C, Figure 2, Effects of Chronic Ethanol Administration on Rat Liver
Proteasome Activities: Relationship With Oxidative Stress |
| Hepatitis
C, Figure 3, Effects of Chronic Ethanol Administration on Rat Liver
Proteasome Activities: Relationship With Oxidative Stress |
| Hepatitis
C, Figure 4, Effects of Chronic Ethanol Administration on Rat Liver
Proteasome Activities: Relationship With Oxidative Stress |
| Hepatitis
C, Figure 5, Effects of Chronic Ethanol Administration on Rat Liver
Proteasome Activities: Relationship With Oxidative Stress |
| Hepatitis
C, table 1, Effects of Chronic Ethanol Administration on Rat Liver
Proteasome Activities: Relationship With Oxidative
Stress | |
|
fibrosis/7 pages
| Hepatitis
C, Slow Progression Rate of Fibrosis in Hepatitis C Virus Patients
With Persistently Normal Alanine Transaminase Activity |
| Hepatitis
C, table 1, Slow Progression Rate of Fibrosis in Hepatitis C Virus
Patients With Persistently Normal Alanine Transaminase
Activity |
| Hepatitis
C, table 2, Slow Progression Rate of Fibrosis in Hepatitis C Virus
Patients With Persistently Normal Alanine Transaminase
Activity |
| Hepatitis
C, Figure 1, Slow Progression Rate of Fibrosis in Hepatitis C Virus
Patients With Persistently Normal Alanine Transaminase
Activity |
| Hepatitis
C, Figure 2, Slow Progression Rate of Fibrosis in Hepatitis C Virus
Patients With Persistently Normal Alanine Transaminase
Activity |
| Hepatitis
C, Figure 3, Slow Progression Rate of Fibrosis in Hepatitis C Virus
Patients With Persistently Normal Alanine Transaminase
Activity |
| Hepatitis
C, REFERENECES, Slow Progression Rate of Fibrosis in Hepatitis C
Virus Patients With Persistently Normal Alanine Transaminase
Activity | |
|
neuropathy/10 pages
| Hepatitis
C, Decreased Muscle Strength in Patients With Alcoholic Liver
Cirrhosis in Relation to Nutritional Status, Alcohol Abstinence,
Liver Function, and Neuropathy |
| Hepatitis
C, table 1, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, table 2, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, Figure 1, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, Figure 2, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, table 3, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, Figure 3, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, Figure 4, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, Figure 5, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis in Relation to Nutritional Status, Alcohol
Abstinence, Liver Function, and Neuropathy |
| Hepatitis
C, References, Decreased Muscle Strength in Patients With Alcoholic
Liver Cirrhosis | |
|
new/2 pages
|
|
normal/7 pages
|
|
prevention/1 pages
|
|
shunt/11 pages
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial |
| Hepatitis
C, Transjugular Intrahepatic Portosystemic Shunt Versus Endoscopic
Sclerotherapy for the Prevention of Variceal Bleeding in Cirrhosis:
A Randomized Multicenter Trial | |
|
surgery/4 pages
|
|
tips/1 pages
|
|
varices/5 pages
|
|
misc/8 pages
| Hepatitis
C, Miscellaneous Information regarding Hepatitis |
| Hepatitis
C, Blood Type Chart, Clinical Trials, Social Security,
Immunizations, Suicide, |
| Hepatitis
C, Speaking the Language of Recombinant DNA |
| Hepatitis
C, Medical Waste: It's Unregulated and Threatening the Health of the
Public |
| Hepatitis
C, Clinical Trials: Difficult, imperfect, expensive--and
necessary |
| | | |
